M. Czapska, K. Babkiewicz, S. Pabis, and K. Skórzyńska-Dziduszko, “Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus”, J Educ Health Sport, vol. 8, no. 12, pp. 335–351, Dec. 2018.